Erschienen in:
01.07.2010 | Case Report
The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis
verfasst von:
Gleb Slobodin, Itzhak Rosner, Doron Rimar, Nina Boulman, Michael Rozenbaum, Majed Odeh
Erschienen in:
Clinical Rheumatology
|
Ausgabe 7/2010
Einloggen, um Zugang zu erhalten
Abstract
A patient with ankylosing spondylitis, after demonstrating incomplete clinical response to adalimumab, received three monthly infusions of pamidronate along with continuing TNF-α blockade. Complete disappearance of the back pain was reported after the second pamidronate infusion. The perspectives of the combination therapy with TNF-α inhibitor and pamidronate are discussed.